Life sciences news
-
eTheRNA raises EUR 34 million in Series B financing to accelerate multiple mRNA therapeutic development programs through to clinical proof of concept
Wednesday June 17th 2020
Read more
-
Fund+ appoints Luc Debruyne and Gérard Lamarche to the Board of Directors
Tuesday June 16th 2020
Read more
-
Mithra signs LSA for commercialization of Tibelia® in Liechtenstein and Switzerland
Thursday June 11th 2020
Read more
-
Johnson & Johnson announces acceleration of its COVID-19 vaccine candidate
Thursday June 11th 2020
Read more
-
Bioqube Ventures launches Bioqube Factory Fund I
Wednesday June 10th 2020
Read more
-
Biotalys expands executive team and establishes U.S. headquarters to strengthen North American presence
Wednesday June 10th 2020
Read more
-
Nieuwe antivirale benadering voor influenza en Zika
Wednesday June 10th 2020
Read more
-
New analyses of Phase 2 Equator Clinical Program support durable efficacy of Filgotinib in Psoriatic Arthritis
Monday June 8th 2020
Read more
-
Become a flanders.bio member
Your news here?
-
Gentse en Leuvense onderzoekers steken turbo in ontwikkeling van nieuw soort antibiotica
Friday June 5th 2020
Read more
-
Belgische start-up BioStrand haalt 2 miljoen euro op
Thursday June 4th 2020
Read more
-
Filgotinib demonstrates durable efficacy and consistent safety profile at 52 weeks in Finch 1 and 3 studies in rheumatoid arthritis
Thursday June 4th 2020
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
